Fig. 6From: Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTMCytokine and cell expression in DM lesional skin treated with Lenabasum versus placebo. Skin biopsies from lesional DM skin stained via immunohistochemistry for a CD4+ cells, b IFN-β, c IFN-γ, d IL-31, e CB2R, f CD11c+ cells, g CD123+ cells, and h CD8+ cells at week 0 and week 12 following treatment with either lenabasum or placebo. Representative IHC images are pictured at ×20 objective magnification. Quantification of cell counts and percentage of area stained positive are pictured adjacently. Cells were counted in five non-overlapping ×40 fields and averaged. Percentage of area stained positive was quantified in one ×20 field. Epidermis excluded. Graph shows the median. *p<0.05Back to article page